West Nile Virus Recombinant DNA Vaccine Protects Mouse and Horse from Virus Challenge and Expresses In Vitro a Noninfectious Recombinant Antigen That Can Be Used in Enzyme-Linked Immunosorbent Assays

Introduction of West Nile (WN) virus into the United States in 1999 created major human and animal health concerns. Currently, no human or veterinary vaccine is available to prevent WN viral infection, and mosquito control is the only practical strategy to combat the spread of disease. Starting with...

Descripció completa

Dades bibliogràfiques

Publicat a:	J Virol
Autors principals:	Davis, Brent S., Chang, Gwong-Jen J., Cropp, Bruce, Roehrig, John T., Martin, Denise A., Mitchell, Carl J., Bowen, Richard, Bunning, Michel L.
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 2001
Matèries:	Vaccines and Antiviral Agents
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC114149/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11287553/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.75.9.4040-4047.2001
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!